Discover Anti-Human CD28: Benefits, Uses, and Expert Insights

Explore the innovative anti-human cd28 antibody from Alpha Lifetech Incorporation, designed for advanced research in immunology and cell biology. This high-affinity antibody is crucial for studying T cell activation and immune responses, playing a vital role in understanding various diseases and therapeutic developments. With a proven track record in enhancing cellular assays and providing reliable results, our anti-human CD28 antibody ensures precise targeting and optimal performance in experimental applications, Engineered through cutting-edge technology, this product reflects our commitment to quality and efficacy, allowing researchers to delve deeper into the mechanisms of T cell regulation. Experience improved experimental outcomes and reproducibility in your studies, With Alpha Lifetech's anti-human CD28 antibody, you gain a powerful tool for advancing your research and facilitating breakthroughs in understanding immune system dynamics. Trust in our expertise and dedication to delivering top-tier research solutions for the scientific community

Hot Selling Product

ALP64650-Recombinant Human CD28 Protein, Fc Tag

ADT1090-Bevacizumab Biosimilar: Anti-Human VEGFA mab- Research Grade

ADT1744-Human Anti-VEGFAxANGPT2 Bispecific Antibody

ADT1749-Human Anti-CD3ExCD20 Bispecific Antibody

ADT1750-Human Anti-CD3xBCMA Bispecific Antibody

ADT1751-Human Anti-CD3xCD19 Bispecific Antibody

The Clear Choice of anti human cd28 More Than a Supplier - A Partner Dominates

In the rapidly evolving landscape of biochemistry and immunology, partnering with a trusted supplier is crucial for success. Alpha Lifetech Inc. stands out as more than just a supplier of anti-human CD28 reagents; we position ourselves as a dedicated partner in your research and development journey. Our company, founded by a team of seasoned scientists with profound expertise in membrane Protein production, nanobody discovery, and monoclonal development, has crafted nearly 10,000 high-quality reagents, including cytokines and drug target antibodies. The significance of anti-human CD28 lies in its essential role in T-cell activation and immune response modulation, making it a critical component in immunological research and therapeutic development. At Alpha Lifetech, we understand the challenges faced by global buyers in sourcing reliable and effective reagents. Our commitment to quality assurance and innovation ensures that you are equipped with products that advance your research objectives seamlessly. Choosing Alpha Lifetech Inc. means embracing a partnership built on scientific excellence and unwavering support. We are dedicated to providing not only high-quality products but also exceptional customer service, technical support, and collaborative opportunities to enhance your work. With our expertise and extensive portfolio, we are here to empower your research and help you navigate the complexities of scientific discovery with confidence and precision. Let’s innovate together.

The Clear Choice of Anti-Human CD28 More Than a Supplier - A Partner Dominates

Feature	Description	Benefits	Applications
High Purity	≥ 95% purity confirmed by SDS-PAGE	Increased reliability in research outcomes	Cell signaling studies
Stability	Stable at -20°C with proven shelf-life	Less waste and extended usability	Long-term experiments
Custom Solutions	Tailored modifications available	Enhanced specificity for varied research demands	Targeted therapy development
Technical Support	Expertise available for all stages of research	Maximized research efficiency	Complex experimental designs
Competitive Pricing	Value-driven cost structures	Cost-effective research solutions	Budget-driven projects

Trends in Anti-Human CD28 Usage Across Different Research Areas

In the realm of biomedical research, the utilization of anti-human CD28 antibodies has surged across various domains of study. This bar chart illustrates the number of publications dedicated to anti-human CD28 in five key research areas: Immunology, Oncology, Neuroscience, Transplantation, and Infectious Disease. Immunology leads as the most prolific field, reflecting the antibody's crucial role in immune response modulation and T-cell activation. Oncology follows, showcasing interest in utilizing this pathway for cancer immunotherapy strategies. Neuroscience, while having fewer publications, highlights growing awareness of the immune system’s impact on neurological disorders. The Transplantation area demonstrates a commitment to enhancing graft acceptance through immune modulation, while research in Infectious Disease reflects the pressing need to understand immune responses to pathogens. This data suggests that collaborations in these priority sectors could significantly advance therapeutic developments and enhance the overall understanding of immunological processes. As such, prospective partners engaged in research should align their efforts to match these trends, capitalizing on the most active areas of investigation.